US Market for Wound and Tissue Management 2014 (Forecasted to 2020) – MedSuite

ReportIcon-Bandage-MS

US Market for Wound and Tissue Management 2014 (Forecasted to 2020) – MedSuite

  • Year: 2014
  • Scope: 2010-2020
  • Region: United States
  • Published Date: 10/01/2014
  • Pages: 353
  • Type: MedSuite

0

The U.S. wound and tissue management market was valued at over $7.8 billion in 2013.
The wound and tissue management market includes wound closure devices; static and dynamic compression therapy; moist, antimicrobial, interactive wound dressings; non-adherent contact layers; hemostats; tissue sealants; anti-adhesion; and negative pressure wound therapy. This report details the expected growth rates, average selling prices (ASP) and market values of these interlinked segments.

    

The U.S market for wound and tissue management was driven by the introduction of newly FDA-approved products, and by demand due to the aging population, and increasing rates of both obesity and diabetes. The advanced wound dressings segment exhibited the highest growth in 2013. This growth will be due to the rising popularity of foam dressings, antimicrobial dressings and the influx of competitors and innovative products in the interactive dressing market. The reimbursement changes in 2014 will potentially have a negative impact on the growth of the interactive dressing market.

The range of products in the wound management industry is as diverse as the conditions they are meant to treat. The use of traditional dressings has stood the test of time and these will remain important products. This market will exhibit slow but healthy growth over the forecast period due to its sheer size. However, advanced dressings are the way of the future and there is still a large untapped potential market. Advanced dressings decrease the frequency a dressing must be changed and due to the commoditization of these products, the price gap between the two, traditional and advanced, is decreasing. Over the forecast period, companies which are able to modify and enhance their advanced dressing portfolio will be able to grow with the shift in product usage.

Growth in the negative pressure wound therapy market was significantly affected by the competitive bidding process. This market is expected to rebound and post growth in the high single-digits over the forecast period. Growth will be supplemented by improved reimbursement rates for single use negative pressure wound therapy pumps and an increase in the number of competitors.

With the baby boomers aging, the total number of people over the age of 65 is drastically increasing within the United States. With an aging population comes the requirement for more surgical procedures, all risking the possibility of circulatory issues. As a result, a greater number of devices used in surgery, such as wound closure devices, hemostats and tissue sealants, will be purchased. Therefore, sales of products that enhance circulation to treat lymphedema and chronic wounds are expected to increase to meet the growing demand of this population.

The wound and tissue management market is consistently changing through new reimbursement rates, FDA approval and product innovation. A company which was once a dominant player in a market can lose market share quickly due to a number of different factors. KCI continues to lead the negative pressure wound therapy market but their revenue was significantly affected by the competitive bidding process, which allowed Smith & Nephew to increase their market share. Shire, a once dominant player in the interactive dressing market, saw their revenue significantly decrease year-over-year due to their highlight product not receiving FDA approval for additional usage.



Ethicon
Covidien
KCI
Medline
Smith & Nephew
3M
Organogenesis
Baxter
Pfizer
Mölnlycke
ConvaTec
BSN-JOBST
C. R. Bard
ArjoHuntleigh
Genzyme
Systagenix
mediUSA
Medicines Company
Integra Lifesciences
SIGVARIS
CryoLife
Z-Medica
Bio Compression Systems
Juzo
HARTMANN-CONCO
Aesculap
Applied Medical
Osiris
Stryker (Orthovita)
Vascular Solutions
Derma Sciences
Bayer
Carolon
Albahealth
Lympha Press
Tactile Medical
MCS
Circulator Boot Corporation
HemCon
Celox




Welcome to the new iData Website!

New Website Discount Extended to Public:

Use Coupon Code “idata15” to Get 15% Off Your Purchase Before September 30, 2016

 

Login

Register

×

Thank you!

CLOSE
Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.

CLOSE

Login

Register

×